Amir Horev
Ben-Gurion University of the Negev
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Amir Horev.
International Journal of Dermatology | 2011
Amir Horev; Adi Y. Weintraub; Ruslan Sergienko; Arnon Wiznitzer; Sima Halevy; Eyal Sheiner
Backgroundu2002 Vitiligo, characterized by destruction of melanocytes, causes a patchy depigmentation of the skin. It has been hypothesized to have an autoimmune pathogenesis. Autoimmune disorders are more common among women and may be associated with adverse pregnancy outcomes, such as recurrent abortions, intrauterine growth restriction (IUGR), and pre‐eclampsia.
Journal of The European Academy of Dermatology and Venereology | 2018
Guy Shalom; E. Magen; Meir Babaev; S. Tiosano; Daniel A. Vardy; D. Linder; Amir Horev; A. Saadia; Doron Comaneshter; N. Agmon‐Levin; Arnon D. Cohen
Emerging evidence suggests that chronic urticaria (CU) is associated with chronic, low‐grade, inflammatory process.
Journal of The American Academy of Dermatology | 2017
Guy Shalom; Meir Babaev; Tamar Freud; Shmuel Tiosano; Nadav Pam; Amir Horev; Jacob Dreiher; Daniel A. Vardy; Doron Comaneshter; Arnon D. Cohen
Background Data on the health care utilization of patients with hidradenitis suppurativa (HS) in primary care settings are scarce. Objective To investigate the health care service utilization of patients with HS. Methods In a cross‐sectional study, patients with HS were compared with 2 age‐ and sex‐matched control groups—general population enrollees of Clalit Health Services and a group of patients with psoriasis. Health care services data included inpatient and outpatient community clinic visits and pharmacy claims for topical and systemic treatments. Multivariate analysis of the data for patients with HS and controls was performed. Results The study included 4417 patients with HS, 22,085 general population enrollees, and 4417 patients with psoriasis. On the basis of multivariate analyses, patients with HS had more annual dermatology clinic visits compared with the general population enrollees (odds ratio [OR], 6.49; 95% confidence interval [CI], 7.06‐5.97) and patients with psoriasis (OR, 1.32; 95% CI, 1.44‐1.21), more annual surgical clinic visits (OR, 3.78; 95% CI 3.28‐4.36 and OR, 1.65; 95% CI, 1.42‐1.91, respectively), and more hospitalizations (OR, 2.21; 95% CI, 1.89‐2.56 and OR, 1.51; 95% CI, 1.28‐1.78, respectively). Limitations Underestimation of HS frequency was possible. Conclusions The burden on health care systems due to patients with HS is greater than that due to patients with psoriasis and the general population.
British Journal of Dermatology | 2016
Guy Shalom; J. Shapiro; Jacob Dreiher; A. Nathan; Tamar Freud; Doron Comaneshter; Amir Horev; R. Khoury; S. Vinker; Arnon D. Cohen
1 NHS National Services Scotland. Cancer statistics, skin cancer. Available at: http://www.isdscotland.org/Health-Topics/Cancer/CancerStatistics/Skin/ (last accessed 16 June 2016). 2 Chapman PB, Hauschild A, Robert C et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 364:2507–16. 3 Hodi FS, O’Day SJ, McDermott DF et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363:711–23. 4 John L, Cowey CL. The rapid emergence of novel therapeutics in advanced malignant melanoma. Dermatol Ther 2015; 5:151–69. 5 Larkin J, Acland K, Algurafi H et al. Melanoma focus group consensus guidelines. 2013 position paper: follow-up of high risk cutaneous melanoma patients in the U.K. Available at: http:// melanomafocus.com/wp-content/uploads/2014/02/CutaneousMelanoma-Follow-Up-Position-Paper-30Jan14.pdf (last accessed 16 June 2016). 6 Marsden JR, Newton-Bishop JA, Burrows L et al. Revised U.K. guidelines for the management of cutaneous melanoma. Br J Dermatol 2010; 163:238–56. 7 National Institute for Health and Care Excellence. Melanoma: assessment and management. NICE guideline NG14. Available at: https://www.nice.org.uk/guidance/ng14 (last accessed 16 June 2016).
International Journal of Dermatology | 2018
Guy Shalom; Devy Zisman; Meir Babaev; Amir Horev; Shmuel Tiosano; Yochai Schonmann; Doron Comaneshter; Arnon D. Cohen
Updated data regarding the epidemiology of psoriasis and related healthcare utilization are lacking.
International Journal of Dermatology | 2018
Yuval Krieger; Tamar Wainstock; Eyal Sheiner; Avi Harlev; Daniella Landau; Amir Horev; Alexander Bogdanov-Berezovsky; Asnat Walfisch
Although concerns have been raised regarding the long‐term health risks of offspring conceived following fertility treatments, limited information is available regarding their health status beyond the neonatal period. We aimed to evaluate the risk of long‐term eruptive dermatological morbidity among children born following fertility treatments as compared to those conceived spontaneously.
British Journal of Dermatology | 2018
Guy Shalom; E. Magen; M. Babaev; Amir Horev; Tamar Freud; G. Ben Yakov; Doron Comaneshter; Daniel A. Vardy; Arnon D. Cohen
The human body interacts with the environment mainly through three major tissues: the lungs, skin, and gastrointestinal (GI) tract. In each one, an intensive nervous network is present, conjugated with abundant mast cells (MC). While MC-mediated disorders in airways and the skin are extensively discussed, MC-mediated disorders of the GI tract remain relatively uncommon. Since the GI tract is one of the three main environment-interacting tissues, it is reasonable that MC-mediated disorders of the GI may have the same weight and impact as asthma or chronic urticaria (CU). n nThis article is protected by copyright. All rights reserved.
Acta Dermatovenerologica Croatica | 2017
Amir Horev; Tamar Freud; Iris Manor; Arnon D. Cohen; Alex Zvulunov
Journal of Pediatrics & Neonatal Care | 2014
Amir Horev; Alex Zvulunov
Journal of Pediatrics & Neonatal Care | 2014
Amir Horev